Insights on common vaccinations in HIV-infection: efficacy and safety




HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complications, with mortality rates higher than in non-HIV-infected individuals. Consequently, international guidelines generally recommend inactivated vaccines in HIV-patients, even if HIV-related immunodeficiency may impair efficacy; live vaccines are usually not recommended in these patients because of safety concerns. The aim of this short article is to review current knowledge about both efficacy and safety of vaccines in HIV-infected individuals.


Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.. Lancet 2012;380(9859):2224-2260. Available from: PubMed PMID: 23245609. doi: 10.1016/S0140-6736(12)61766-8.

Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I. Community-acquired opportunistic infections and defective cellular immunity in heterosexual drug abusers and homosexual men. Am J Med 1983;74(3):433-441. Available from: PubMed PMID: 6219579. doi: 10.1016/0002-9343(83)90970-1. [Google Scholar]

Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.. Ann Intern Med 1989 Aug;111(3):223-231. Available from: PubMed PMID: 2546472. doi: 10.7326/0003-4819-111-3-223. [Google Scholar]

Ghani AC, de Wolf F, Ferguson NM, Donnelly CA, Coutinho R, Miedema F, et al. Surrogate Markers for Disease Progression in Treated HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 2001;28(3):226-231. Available from: doi: 10.1097/00042560-200111010-00004. [Google Scholar]

Brien, W.A. O' , Hartigan PM, Daar ES, et al. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 1997;126(12):939. Available from: doi: 10.7326/0003-4819-126-12-199706150-00002. [Google Scholar]

Brien, W.A. O' , Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334(7):426-431. Available from: doi: 10.1056/NEJM199602153340703. [Google Scholar]

Moir S, Fauci AS. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008;122(1):12-19. Available from: PubMed PMID: 18547629. doi: 10.1016/j.jaci.2008.04.034. [Google Scholar]

Achievements in Public Health, (1900-1999) . Control of infectious diseases. MMWR Wkly 1999;48:621. [Google Scholar]

Wolter N, Cohen C, Tempia S, Madhi SA, Venter M, Moyes J, et al. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011.. J Infect Dis 2013 Aug;209(1):56-65. Available from: PubMed PMID: 23922370. doi: 10.1093/infdis/jit427. [Google Scholar]

Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia. Mortality in acquired immunodeficiency syndrome.. Chest 1992;101(1):150-155. Available from: PubMed PMID: 1729061. doi: 10.1378/chest.101.1.150. [Google Scholar]

Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature. Clin Infect Dis Off Publ Infect Dis Soc Am 2011;52(2):219-227. Available from: PubMed PMID: 21288848. doi: 10.1093/cid/ciq110. [Google Scholar]

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. n.d.

Linee Guida Italiane sull'utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1 2013.

Kroger AT, Sumaya CVS, Pickering L, et al. General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP) 2011;1:60–60

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005;19(6):593-601. Available from: PubMed PMID: 15802978. doi: 10.1097/01.aids.0000163936.99401.fe. [Google Scholar]

Thio CL, Seaberg EC, Skolasky Jr R, Phair J, Visscher B, Muñoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).. Lancet 2002 Dec;360(9349):1921-1926. Available from: PubMed PMID: 12493258. [Google Scholar]

Ochnio JJ, Patrick D, Ho M, et al. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ Can Med Assoc J J Assoc Medicale Can 2001;165(3):293-297. Available from: PubMed PMID: 11517645. [Google Scholar]

Villano SA, Nelson KE, Vlahov D, et al. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis Off Publ Infect Dis Soc Am 1997;25(3):726-728. Available from: PubMed PMID: 9314468. doi: 10.1086/513757. [Google Scholar]

Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.. J Natl Cancer Inst 2000;92(18):1500-1510. Available from: PubMed PMID: 10995805. doi: 10.1093/jnci/92.18.1500. [Google Scholar]

Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS.. J Natl Cancer Inst 2009 Jul;101(16):1120-1130. Available from: PubMed PMID: 19648510. doi: 10.1093/jnci/djp205. [Google Scholar]

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.. J Natl Cancer Inst 2005 Mar;97(6):425-432. Available from: PubMed PMID: 15770006. doi: 10.1093/jnci/dji072. [Google Scholar]

Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am 2010;51(8):957-962. Available from: doi: 10.1086/656416. [Google Scholar]

Dal Maso, L. , Polesel J, Serraino D, Lise M, Piselli P, Falcini F, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009 Feb;100(5):840-847. Available from: PubMed PMID: 19223894. doi: 10.1038/sj.bjc.6604923. [Google Scholar]

Rodriguez-Barradas MC, Goulet J, Brown S, et al. Impact of pneumococcal vaccination on the incidence of pneumonia by hiv infection status among patients enrolled in the veterans aging cohort 5-site study. Clin Infect Dis Off Publ Infect Dis Soc Am 2008;46(7):1093-1100. Available from: PubMed PMID: 18444830. doi: 10.1086/529201. [Google Scholar]

Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety.. Vaccine 2014;32(43):5585-5592. Available from: PubMed PMID: 25131742. doi: 10.1016/j.vaccine.2014.07.101. [Google Scholar]

Landrum ML, Hullsiek KH, Ganesan A, Weintrob AC, Crum-Cianflone NF, Barthel, R Vincent, , et al. Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals. AIDS 2010;24(4):545-555. Available from: doi: 10.1097/QAD.0b013e32832cd99e. [Google Scholar]

Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, et al. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya.. J Infect Dis 2012 Nov;207(3):402-410. Available from: PubMed PMID: 23175769. doi: 10.1093/infdis/jis695. [Google Scholar]

Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination.. Ann Intern Med 1988 Jul;109(2):101-105. Available from: PubMed PMID: 2968064. doi: 10.7326/0003-4819-109-2-101. [Google Scholar]

Neilsen GA, Bodsworth NJ, Watts N. Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men.. J Infect Dis 1997;176(4):1064-1067. Available from: PubMed PMID: 9333168. doi: 10.1086/516512. [Google Scholar]

Wallace MR, Brandt CJ, Earhart KC, et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIVinfected subjects. Clin Infect Dis Off Publ Infect Dis Soc Am 2004;39(8):1207-1213. Available from: doi: 10.1086/424666. [Google Scholar]

Tseng YT, Chang SY, Liu WC, et al. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men. Hepatology 2013;57(5):1734-1741. Available from: PubMed PMID: 23258666. doi: 10.1002/hep.26210. [Google Scholar]

Kahn JA, Xu J, Kapogiannis BG, et al. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis Off Publ Infect Dis Soc Am 2013;57(5):735-744. Available from: PubMed PMID: 23667266. doi: 10.1093/cid/cit319. [Google Scholar]

Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.. J Infect Dis 2010 Oct;202(8):1246-1253. Available from: PubMed PMID: 20812850. doi: 10.1086/656320. [Google Scholar]

Calmy A, Bel M, Nguyen A, Combescure C, Delhumeau C, Meier S, et al. Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients. HIV Med 2011 Nov;13(4):207-218. Available from: PubMed PMID: 22093373. doi: 10.1111/j.1468-1293.2011.00961.x. [Google Scholar]

Onlamoon N, Unpol P, Boonchan M, Sukapirom K, Wittawatmongkol O, Chokephaibulkit K, et al. Immune activation and viral replication after vaccination with an influenza A H1N1 2009 vaccine in HIV-infected children receiving antiretroviral therapy.. Dis Markers 2013;35(4):221-227. Available from: PubMed PMID: 24167370. doi: 10.1155/2013/276547. [Google Scholar]

Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, et al. Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.. J Infect Dis 2010 Oct;202(8):1246-1253. Available from: PubMed PMID: 20812850. doi: 10.1086/656320. [Google Scholar]

Levin MJ, Gershon AA, Weinberg A, Song L, Fentin T, Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.. J Infect Dis 2006 Jun;194(2):247-255. Available from: PubMed PMID: 16779732. doi: 10.1086/505149. [Google Scholar]

Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.. N Engl J Med 1996 May;334(19):1222-1230. Available from: PubMed PMID: 8606717. doi: 10.1056/NEJM199605093341903. [Google Scholar]

Delaugerre C, Gallien S, Flandre P, et al. Impact of low-levelviremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients. PloS One 2012;7(5). Available from: PubMed PMID: 22590588. doi: 10.1371/journal.pone.0036673. [Google Scholar]

Laprise C, Pokomandy A, Baril JG, et al. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation. Clin Infect Dis Off Publ Infect Dis Soc Am 2013;57(10):1489-1496. Available from: doi: 10.1093/cid/cit529. [Google Scholar]

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001;20(3-4):545-553. Available from: PubMed PMID: 11672921. doi: 10.1016/S0264-410X(01)00347-4. [Google Scholar]

Launay O, van der Vliet, (Diane) , Rosenberg AR, Michel M, Piroth L, Rey D, et al. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.. JAMA 2011 Apr;305(14):1432-1440. Available from: PubMed PMID: 21486976. doi: 10.1001/jama.2011.351. [Google Scholar]

Madhi SA, Maskew M, Koen A, et al. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis Off Publ Infect Dis Soc Am 2011 Jan;52(1):128-137. Available from: PubMed PMID: 21148531. doi: 10.1093/cid/ciq004. [Google Scholar]

King JC, Treanor J, Fast PE, et al. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000;181(2):725-728. Available from: doi: 10.1086/315246. [Google Scholar]

Perry RT, Plowe CV, Koumaré B, Bougoudogo F, Kotloff KL, Losonsky GA, et al. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.. Bull World Health Organ 1998;76(1):63-71. Available from: PubMed PMID: 9615498. [Google Scholar]

Barte H, Horvath TH, Rutherford GW. Yellow fever vaccine for patients with HIV infection.. Cochrane Database Syst Rev 2014 Jan;1. Available from: PubMed PMID: 24453061. doi: 10.1002/14651858.CD010929.pub2. [Google Scholar]

Angel JB, Walpita P, Lerch RA, et al. Vaccine-associated measles pneumonitis in an adult with AIDS. Ann Intern Med 1998;129(2):104. Available from: doi: 10.7326/0003-4819-129-2-199807150-00007. [Google Scholar]

Kramer JM, LaRussa P, Tsai WC, Carney P, Leber SM, Gahagan S, et al. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.. . Available from: PubMed PMID: 11483849. [Google Scholar]

Boudes P, Sobel A, Deforges L, et al. Disseminated Mycobacterium bovis infection from BCG vaccination and HIV infection. JAMA 1989;262(17):2386. Available from: doi: 10.1001/jama.1989.03430170046020. [Google Scholar]

Ninane J, Grymonprez A, Burtonboy G, Francois A, Cornu G. Disseminated BCG in HIV infection. Arch Dis Child 1988;63(10):1268-1269. Available from: PubMed PMID: 3196057. doi: 10.1136/adc.63.10.1268. [Google Scholar]

Berkowitz EM, Moyle G, Stellbrink H, Schürmann D, Kegg S, Stoll M, et al. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.. J Infect Dis 2014 Nov;211(8):1279-1287. Available from: PubMed PMID: 25371534. doi: 10.1093/infdis/jiu606. [Google Scholar]